Palm oil in lipid-based formulations and drug delivery systems

• 出版年: Biomolecules
• 第一著者: 2-s2.0-85061870178
• フォーマット: Review
• 言語: English
• 出版事項: MDPI AG 2019
• オンライン･アクセス: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061870178&doi=10.3390%2fbiom9020064&partnerID=40&md5=99aa5040c8c6a3f97bde17c103c3ddef

Palm oil is natural oil packed with important compounds and fatty acids ready to be exploited in lipid-based formulations and drug delivery. Palm oil and palm kernel oil contain long-chain and medium-chain triglycerides, respectively, including phytonutrients such as tocotrienol, tocopherol and carotenes. The exploitation of these compounds in a lipid-based formulation would be able to address hydrophobicity, lipophilicity, poor bioavailability and low water-solubility of many current drugs. The utilisation of palm oil as part of the drug delivery system seemed to improve the bioavailability and solubility of the drug, stabilising emulsification of formulation between emulsifier and surfactant, promoting enhanced drug permeability and performance, as well as extending the shelf-life of the drug. Despite the complexity in designing lipid-based formulations, palm oil has proven to offer dynamic behaviour in providing versatility in drug design, form and delivery. However, the knowledge and application of palm oil and its fractions in lipid-based formulation are scarce and interspersed. Therefore, this study aims to focus on the research and outcomes of using palm oil in lipid-based formulations and drug delivery systems, due to the importance of establishing its capabilities and benefits. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.